Publication:
Neuromyelitis optica spectrum disorder in patient with systemic lupus erythematosus – Our experience; [Bolesti spektra optičkog neuromijelitisa kod bolesnice sa sistemskim eritemskim lupusom – Naše iskustvo]

dc.contributor.authorBožić, Ksenija (6603672302)
dc.contributor.authorKomatina, Nenad (56516845100)
dc.contributor.authorPetronijević, Milan (6602635159)
dc.contributor.authorKnežević, Bojana (25642850800)
dc.contributor.authorKostić, Dejan (8619696100)
dc.contributor.authorStefanović, Dušan (7006269465)
dc.date.accessioned2025-06-12T16:51:40Z
dc.date.available2025-06-12T16:51:40Z
dc.date.issued2018
dc.description.abstractIntroduction. Neuromyelitis optica spectrum disorder (NMOSD) is a rare demyelinating immune-mediated central nervous system disease. It is extremely rare to occur in patients with systemic lupus erythematosus (SLE), and it represents a diagnostic and therapeutic challenge. Case report. A 38-year-old Caucasian woman with medical history of SLE and new onset of flaccid paraparesis, fecal and urinary incontinence, persistent nausea and vomiting was admitted to our hospital. Based on the clinical presentation, magnetic resonance imaging findings and positive aquaporin 4 (AQP4) antibodies, a NMOSD with coexisting SLE were diagnosed. Pulse-doses of cyclophosphamide and glucocorticoids were efficient in patient treatment. Conclusion. In a patient with SLE and symptoms of longitudinal extensive transverse myelitis and/or optic neuritis and area postrema syndrome, assessment of AQP4 antibodies is neccessary for diagnosing NMOSD. Accurate diagnosis, and timely and long-term administration of immunosuppressive therapy are crucial for favorable outcome of these two coexisting diseases. © 2018, Institut za Vojnomedicinske Naucne Informacije/Documentaciju. All rights reserved.
dc.identifier.urihttps://doi.org/10.2298/VSP160331322B
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85042274247&doi=10.2298%2fVSP160331322B&partnerID=40&md5=c39360f9fe548a5bc9181e9e320cc2ab
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/6679
dc.subjectAntibodies
dc.subjectAquaporin-4
dc.subjectDiagnosis
dc.subjectDrug therapy
dc.subjectLupus erithematosus
dc.subjectNeuromyelitis optica
dc.subjectSystemic
dc.subjectTreatment outcome
dc.titleNeuromyelitis optica spectrum disorder in patient with systemic lupus erythematosus – Our experience; [Bolesti spektra optičkog neuromijelitisa kod bolesnice sa sistemskim eritemskim lupusom – Naše iskustvo]
dspace.entity.typePublication

Files